StockData
CapsoVision, Inc logo

CapsoVision, Inc (CV) stock

CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30733% above fair value
$6.65+0.18 (+2.78%)

Close on Nov 17, 2026Market cap $332.81MP/E –Yield –

CapsoVision price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

CapsoVision's price to book ratio was 23.8× on Nov 11, 2026, against 12.8× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202623.8×−0.6
2025Dec 31, 202524.5×–

More CapsoVision figures

See a number that looks wrong?